Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)
Information source: Dresden University of Technology
Information obtained from ClinicalTrials.gov on February 07, 2013
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Acne Papulopustulosa
Intervention: Adapalen (Drug); VIS and wIRA (Radiation)
Phase: Phase 4
Status: Recruiting
Sponsored by: Dresden University of Technology Official(s) and/or principal investigator(s):
Roland Aschoff, MD, Principal Investigator, Affiliation: Technische Universität Dresden, Fetscher Str. 74, 01307 Dresden, Germany
Overall contact:
Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de
Summary
The aim of the study is to investigate the effectivity of visible light in combination with
waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and
non-inflammatory lesions within 8 weeks will be measured and compared with the standard
treatment with Adapalene.
Clinical Details
Official title: Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy
Eligibility
Minimum age: 14 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4
- At least 5 inflammatory and 5 non-inflammatory lesions in the face
- Age >= 14 years
Exclusion Criteria:
- pregnant and nursing women
- Antiandrogen therapy
- therapy with antibiotics within the last 4 weeks
- therapy with retinoids within the last 6 months
- natural or artificial UV-therapy within the last 4 weeks
- severe acne papulopustulosa according to Burton Scale 5 or 6
- Severe systemic condition
- Secondary acne
Locations and Contacts
Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Sachsen 01307, Germany; Recruiting
Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de
Additional Information
Starting date: September 2006
Last updated: May 13, 2009
|
